drug

BrainWorks

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Mclean Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Treatment to Enhance Cognition in Bipolar Disorder
NCT01470781—Completed

KOLs & investigators

1
Kathryn E Lewandowski, Ph.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Mclean Hospital
company
trial
Treatment to Enhance Cognition in Bipolar Disorder
NA
trial
indication
Psychosis
indication
Bipolar Disorder
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
KOL
Kathryn E Lewandowski, Ph.D.
KOL score —
person